DRW Securities LLC Buys 1,716 Shares of CME Group Inc. (NASDAQ:CME)

DRW Securities LLC raised its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 141.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,925 shares of the financial services provider's stock after purchasing an additional 1,716 shares during the period. DRW Securities LLC's holdings in CME Group were worth $679,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. SJS Investment Consulting Inc. lifted its stake in CME Group by 570.6% during the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares during the period. New Age Alpha Advisors LLC lifted its position in shares of CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after buying an additional 43 shares during the period. Financial Life Planners acquired a new stake in CME Group in the 4th quarter valued at $32,000. Knuff & Co LLC bought a new stake in CME Group in the fourth quarter valued at $33,000. Finally, Fortitude Family Office LLC raised its stake in CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock worth $35,000 after acquiring an additional 83 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CME has been the topic of several analyst reports. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $256.00 to $257.00 and gave the stock a "market perform" rating in a report on Friday, February 14th. JPMorgan Chase & Co. raised their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an "underweight" rating in a report on Thursday, February 13th. Piper Sandler lifted their target price on shares of CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Barclays increased their price target on CME Group from $263.00 to $279.00 and gave the stock an "equal weight" rating in a research report on Monday, April 7th. Finally, Citigroup lowered CME Group from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $255.00 to $250.00 in a research note on Monday, January 6th. Four analysts have rated the stock with a sell rating, seven have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus target price of $247.47.

Remove Ads

Insiders Place Their Bets

In related news, insider Hilda Harris Piell sold 3,984 shares of the company's stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the sale, the insider now owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the sale, the director now owns 21,873 shares of the company's stock, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock valued at $6,871,496 in the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of CME Group stock traded up $1.42 on Tuesday, reaching $265.11. 555,287 shares of the stock were exchanged, compared to its average volume of 2,133,670. The firm's 50 day moving average is $255.66 and its 200-day moving average is $239.56. The firm has a market cap of $95.53 billion, a PE ratio of 27.42, a P/E/G ratio of 6.76 and a beta of 0.43. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a one year low of $190.70 and a one year high of $273.42.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping analysts' consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This is an increase from CME Group's previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a yield of 1.89%. CME Group's dividend payout ratio (DPR) is currently 51.71%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.